Strategic Acquisition Riverpoint Medical recently became part of Novanta Inc. through a deal valued up to 1.45 billion, signaling expanded access to global distribution networks, enhanced recurring revenue potential, and increased credibility with healthcare systems—a strong signal for channel partnerships and OEM collaborations.

Expanded Manufacturing Expansion of facilities to Costa Rica and investments in new manufacturing sites indicate capacity growth and regional diversification, presenting opportunities to discuss supply chain resilience, nearshoring benefits, and cost-effective sourcing for both veterinary and human medical devices.

Premium Sutures As one of the few US suture manufacturers with expertise in synthetic absorbable and orthopedic sutures, Riverpoint Medical can be a compelling partner for OEMs seeking high-performance suture materials, private-label opportunities, and integrated device-suture solutions in sports medicine and orthopedic markets.

Diversified Portfolio Beyond sutures, the company offers LED surgical headlights and oncology needles, enabling cross-sell opportunities into operating room equipment bundles, consumable add-ons, and complementary devices to existing surgical suites and veterinary practices.

Regulatory Readiness With ISO 13485 certification and a data-driven tech stack including JMP and Oracle, Riverpoint Medical demonstrates robust quality and regulatory readiness, making them an attractive partner for customers seeking compliant, scalable manufacturing for new device launches and private-label programs.